Improzone

Season 2 Miniseries Episode 4.3 is officially live. New Improzone Podcast Episode In this episode, Jane Urban sits down with Jason Harlander (Executive Director, Technology Management, Improzo) to explore what the future of CRM in life sciences could look like and why the next evolution of CRM is less about technology and more about creating value for the people who use it every day. Key takeaways...

Season 2 Miniseries Episode 4.2 is officially live. New Improzone Podcast EpisodeIn this episode, Jane Urban sits down with Jason Harlander (Executive Director, Technology Management, Improzo) to unpack the present-day realities of CRM transformation, where life sciences, data, and technology intersect, and where teams are now being forced to make some of their most critical platform decisions. Ke...

Season 2 Episode 4.1 is officially live. New Improzone Podcast Episode In this episode, Jane Urban sits down with Jason Harlander (Executive Director, Technology Management, Improzo) to explore the origins of CRM in life sciences and how early decisions continue to shape the industry today. Key takeaways: * How Salesforce started as a SaaS disruptor and built the foundation for modern CRM * Why Ve...

New Improzone Podcast Episode Jane Urban sits down with Navdeep Singh (AWS Customer Success Leader) to explore Perception vs. Perspective: Rethinking AI Adoption in Biopharma, a conversation that goes beyond the hype to examine how AI is actually being adopted across life sciences organizations today. Key takeaways: • The gap between how AI is perceived and how it performs in real-world settings •...

New Improzone Podcast Episode Jane Urban sits down with Stephen Gatchell (Ortecha) to explore how MDM and AI are evolving together — and why the “golden record” mindset no longer works at scale. Key takeaways:• MDM is shifting from rigid systems of truth to context-driven data philosophies• AI-enabled documentation, observability, and metadata enrichment are changing how data is mastered• Small la...

Most biotech companies are stuck in "pilot purgatory" with Generative AI. But moving from a fun experiment to a scalable, enterprise-grade solution requires more than just a software license, it demands a fundamental shift in how IT partners with Legal, QA, and Regulatory teams. In the Season 2 premiere of The Improzone , host Jane Urban sits down with Andrew Schwartz (Head of Global IT, KalVista...

We are LIVE with the finale of our mini-series! In Episode 4.4 - The AI Adoption Arc, we shift the focus outward to exploring Externally Facing AI Tools. While internal efficiencies are critical, the true competitive advantage in Life Sciences lies in how AI reshapes your customer touchpoints. From personalized HCP engagement to responsive patient support, we unpack how to deploy AI that builds tr...

In the latest episode of The Improzone Mini-Series 4.3, we explore the critical shift from legal compliance to technical verification. Key Insight: Treat your third-party AI like an "over-eager intern"—talented, capable, but lacking the judgment to represent your brand without supervision. In this episode, we unpack: - The Limits of Questionnaires: Why paper surveys fail to catch GenAI h...

In Part 2 of The AI Adoption Arc, we break down the critical shift to building proprietary LLM agents. Discover the severe security vulnerabilities introduced by prompt injection and data contamination in custom workflows. Learn how to implement use-case specific guardrails to achieve measurable, compliant scale. #AICapability #DigitalTransformation #LifeSciencesTech #ComplianceByDesign #AIStrateg...

How do life sciences organizations move from AI buzzwords to business impact? In this episode of The Improzone, discover how to start small, build trust, and make AI your co-pilot for smarter pharma decisions. Watch now and learn how real innovation begins. #Improzone #AIInPharma #Improzo #LifeSciencesAI #HealthcareInnovation #AIAdoption #DataDrivenDecisions

Here comes our 3rd podcast of the ImproZone! Join host Jane Urban and Indy Sawhney (AWS) as this episode speaks directly on the execution of Generative AI in Life Sciences . We dive into how #GenerativeAI is: Enhancing human performance in R&D and commercial roles. Enabling faster, smarter insights across global biopharma operations. Moving from AI strategy to an actionable execution plan . Li...

New Podcast Episode of The Improzone! Can AI and privacy coexist in pharma? In this episode, our host Jane Urban talks to Improzo's Abhishek Trigunait and Enkrypt AI's Nathan Trueblood about making responsible AI a reality. We're exploring the future of AI in Lifesciences, focusing on data privacy, compliance, and the power of strategic partnerships. Watch Now and secure the future of your AI stra...

You’re about to enter a new dimension—where AI doesn’t just sit in dashboards, it makes decisions. Improzo CEO Inderpreet Kambo joins host Jane Urban to talk about building modular, pharma-native AI agents that work where users already are—from Veeva to Salesforce. Why do most pharma AI programs fail? And how do you go from “insight” to actual impact? Step into The Improzone. 🎧 Listen now.